WCLC 2026 preview covering lung cancer treatment trends, antibody-drug conjugates, EGFR therapies, precision oncology and AI.

WCLC 2026 Preview: Emerging Lung Cancer Therapies and Competitive Trends

WCLC 2026 at a glance At IASLC-WCLC 2026, where will the next wave of…


ELCC 2026 lung cancer conference preview covering NSCLC, SCLC, emerging therapies and artificial intelligence.

ELCC 2026 Preview: Key Competitive Shifts in Lung Cancer

ELCC 2026 at a glance ELCC 2026 highlights key lung cancer treatment trends,…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Zelgen × AbbVie option-to-license on alveltamig

Lucid Diligence Brief: Zelgen × AbbVie option-to-license on alveltamig…


Onco_background

Oncology Weekly News - August 18th 2025

🔬🧬 Oncology Updates: Keytruda Approval, Nanobody Breakthrough, Radioligand Deal…


Onco_background

Oncology Weekly News - June 9th 2025

🔬🧬 Oncology Updates: IMDELLTRA Breakthroughs, Breast Cancer Advances, and…


Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - June 5th 2025

This Week in Gene & Cell Therapy: Breakthrough Trials, Fast Track…


Onco_background

Oncology Weekly News - May 26th 2025

🧬🚀Oncology Update: Breakthrough Trials, Drug Approvals & New Therapies.…


ELCC 2025_Preview_by_LucidQuest

ELCC 2025 Preview: Key Lung Cancer Highlights to Watch

ELCC 2025 at a glance Looking toward ELCC 2025, LucidQuest highlights…


Privacy Preference Center